Cover Image

Revisiting the "jelly-roll" technique: New utility in diagnosing linear IgA bullous dermatosis mimicking toxic epidermal necrolysis

Saved in:

Bibliographic Details
Main Authors:	Samavia Khan, BS (Author), Edward Bae, MD (Author), Regine J. Mathieu, MD (Author), Christopher Elco, MD, PhD (Author), Cathy M. Massoud, MD (Author), Elnaz F. Firoz, MD (Author)
Format:	Book
Published:	Elsevier, 2023-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Toxic epidermal necrolysis-like linear IgA bullous dermatosis after third Moderna COVID-19 vaccine in the setting of oral terbinafine
by: Joseph Han, BS, et al.
Published: (2022)

Toxic epidermal necrolysis-like linear IgA bullous dermatosis as a manifestation of multiple drug hypersensitivity in the setting of drug reaction with eosinophilia and systemic symptoms
by: Scott Stratman, MD, MPH, et al.
Published: (2024)

Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis
by: Connie Qiu, BS, et al.
Published: (2020)

Enfortumab vedotin toxic epidermal necrolysis-like blistering dermatosis: A case series and review of the literature
by: Bushra Khanjar, MD, et al.
Published: (2024)

Linear IgA bullous dermatosis preceding a diagnosis of Crohn's disease
by: Nakisa B. Sadeghi, MPH, et al.
Published: (2023)

Development of cyclosporine-induced linear IgA bullous dermatosis despite concurrent use of dapsone
by: Karissa Libson, BA, et al.
Published: (2023)

Linear IgA bullous dermatosis
by: L. F. Znamenskaya, et al.
Published: (2019)

Combined dapsone and sulfapyridine for the treatment of therapy-resistant linear IgA bullous dermatosis: Two case reports
by: Laura Krogh Herlin, MD, et al.
Published: (2022)

Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab
by: Dmitry Nedosekin, PhD, et al.
Published: (2021)

IgA LINEAR BULLOUS DERMATOSIS IN CHILDHOOD.
by: Ivelina Yordanova, et al.
Published: (2015)

Rituximab for linear IgA bullous dermatosis
by: Rummit Dhillon, et al.
Published: (2022)

Letter in reply: Linear IgA bullous dermatosis treated with dupilumab in a pediatric patient with glucose-6-phosphate dehydrogenase deficiency
by: Sonal Muzumdar, MD, et al.
Published: (2024)

Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma
by: Fatima Bawany, MD, et al.
Published: (2023)

Linear IgA and IgG bullous dermatosis
by: Karina de Almeida Pinto Fernandes, et al.
Published: (2016)

Research progress on linear IgA bullous dermatosis
by: Mei WU, et al.
Published: (2023)

Relapsing toxic epidermal necrolysis following COVID-19
by: Feben Messele, BS, et al.
Published: (2024)

Paraneoplastic pemphigus mimicking toxic epidermal necrolysis: An underdiagnosed entity?
by: R. Matthew McLarney, MD, et al.
Published: (2018)

VANCOMYCIN-INDUCED LINEAR IGA BULLOUS DERMATOSIS WITH ISOMORPHIC RESPONSE
by: Tatsuhiko Mori, et al.
Published: (2013)

Linear IGA bullous dermatosis in Tunisian children : 31 cases
by: Kharfi Monia, et al.
Published: (2011)

Linear IgA bullous dermatosis: report of an exuberant case
by: Beatriz Cavalcanti de Souza, et al.
Published: (2013)

Photodistributed toxic epidermal necrolysis in association with lamotrigine and tanning bed exposure
by: Kristen Russomanno, MD, et al.
Published: (2021)

A case of linear IgA bullous dermatosis in a glucose-6-phosphate dehydrogenase-deficient child successfully treated with oral erythromycin and topical tacrolimus
by: Michelle Ann Ramos, MD, et al.
Published: (2023)

Reply to: "Photodistributed toxic epidermal necrolysis in association with lamotrigine and tanning bed exposure"
by: Leonardo Tjahjono, MD, et al.
Published: (2022)

Unusual clinicopathological and immunological presentation of chronic bullous dermatosis of childhood (linear IgA dermatosis)
by: Al-Saif Fahad, et al.
Published: (2011)

Toxic epidermal necrolysis-like toxic erythema of chemotherapy: 2 illustrative cases
by: Angela Lu, BA, et al.
Published: (2021)

An Unusual presentation of Bullous pemphigoid: A toxic epidermal necrolysis variant
by: Ravina Naik, et al.
Published: (2022)

Adult linear IgA bullous dermatosis: report of three cases
by: Taila Yuri Siqueira Machado, et al.
Published: (2018)

Heparin-induced bullous hemorrhagic dermatosis: A report of 3 cases
by: Madeline R. Frizzell, MS, et al.
Published: (2020)

Successful treatment of linear immunoglobulin A bullous dermatosis with dupilumab in a pediatric patient
by: Nouf Almuhanna, MD, et al.
Published: (2023)

Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis
by: Amanda Regio Pereira, et al.
Published: (2016)

Toxic epidermal necrolysis caused by etonogestrel implantation: A rare presentation
by: Minorvi Amin, BS, et al.
Published: (2022)

A rare presentation of enfortumab vedotin-induced toxic epidermal necrolysis
by: Andrea Francis, BS, et al.
Published: (2021)

Dapsone-responsive inflammatory dermatitis with features of subcorneal pustular dermatosis and bullous pemphigoid
by: Shilpa Ghatnekar, MS, et al.
Published: (2022)

Successful treatment of subcorneal pustular dermatosis targeting an underlying monoclonal IgA gammopathy
by: Ina Kreyberg, MD, PhD, et al.
Published: (2023)

A case of linear IgA bullous dermatosis successfully treated with omalizumab
by: Nayankumar H Patel, et al.
Published: (2020)

Linear IgA bullous dermatosis induced by atezolizumab: a case report
by: Seba Almutairi, et al.
Published: (2024)

Diffuse cutaneous mastocytosis masquerading as linear IgA bullous dermatosis of childhood
by: Tuntas Rayinda, et al.
Published: (2021)

A case of pembrolizumab-induced toxic epidermal necrolysis with a delayed developmental timeline
by: William Driscoll, BS, et al.
Published: (2024)

Wells syndrome as a presenting sign of COVID-19 in the setting of allergic rhinitis and iron deficiency anemia
by: Isabelle Moseley, AB, et al.
Published: (2022)

Treatment of toxic epidermal necrolysis and concurrent COVID-19-associated hyperinflammatory syndrome with systemic corticosteroids and etanercept
by: Rachel Choi, MD, et al.
Published: (2022)